Literature DB >> 29632246

Heightened Systemic Levels of Neutrophil and Eosinophil Granular Proteins in Pulmonary Tuberculosis and Reversal following Treatment.

Kadar Moideen1, Nathella Pavan Kumar1, Dina Nair2, Vaithilingam V Banurekha2, Ramalingam Bethunaickan3, Subash Babu4,5.   

Abstract

Granulocytes are activated during Mycobacterium tuberculosis infection and act as immune effector cells, and granulocyte responses are implicated in tuberculosis (TB) pathogenesis. Plasma levels of neutrophil and eosinophil granular proteins provide an indirect measure of degranulation. In this study, we wanted to examine the levels of neutrophil and eosinophil granular proteins in individuals with pulmonary tuberculosis (PTB) and to compare them with the levels in individuals with latent TB (LTB). Hence, we measured the plasma levels of myeloperoxidase (MPO), neutrophil elastase, proteinase 3, major basic protein (MBP), eosinophil-derived neurotoxin (EDN), eosinophil cationic protein (ECP), and eosinophil peroxidase (EPX) in these individuals. Finally, we also measured the levels of all of these proteins in PTB individuals following antituberculosis treatment (ATT). Our data reveal that PTB individuals are characterized by significantly higher plasma levels of MPO, elastase, proteinase 3, as well as MBP and EDN in comparison to those in LTB individuals. Our data also reveal that ATT resulted in the reversal of all of these changes, indicating an association with TB disease. Finally, our data show that the systemic levels of MPO and proteinase 3 can significantly discriminate PTB from LTB individuals. Thus, our data suggest that neutrophil and eosinophil granular proteins could play a potential role in the innate immune response and, therefore, the pathogenesis of pulmonary TB.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  eosinophils; granular proteins; neutrophils; tuberculosis

Mesh:

Substances:

Year:  2018        PMID: 29632246      PMCID: PMC5964507          DOI: 10.1128/IAI.00008-18

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  Escape of Mycobacterium tuberculosis from oxidative killing by neutrophils.

Authors:  Björn Corleis; Daniel Korbel; Robert Wilson; Johan Bylund; Ronnie Chee; Ulrich E Schaible
Journal:  Cell Microbiol       Date:  2012-04-13       Impact factor: 3.715

2.  Neutrophils are the predominant infected phagocytic cells in the airways of patients with active pulmonary TB.

Authors:  Seok-Yong Eum; Ji-Hye Kong; Min-Sun Hong; Ye-Jin Lee; Jin-Hee Kim; Soo-Hee Hwang; Sang-Nae Cho; Laura E Via; Clifton E Barry
Journal:  Chest       Date:  2009-09-11       Impact factor: 9.410

3.  Heightened plasma levels of heme oxygenase-1 and tissue inhibitor of metalloproteinase-4 as well as elevated peripheral neutrophil counts are associated with TB-diabetes comorbidity.

Authors:  Bruno B Andrade; Nathella Pavan Kumar; Rathinam Sridhar; Vaithilingam V Banurekha; Mohideen S Jawahar; Thomas B Nutman; Alan Sher; Subash Babu
Journal:  Chest       Date:  2014-06       Impact factor: 9.410

4.  CXCL5-secreting pulmonary epithelial cells drive destructive neutrophilic inflammation in tuberculosis.

Authors:  Geraldine Nouailles; Anca Dorhoi; Markus Koch; Jens Zerrahn; January Weiner; Kellen C Faé; Frida Arrey; Stefanie Kuhlmann; Silke Bandermann; Delia Loewe; Hans-Joachim Mollenkopf; Alexis Vogelzang; Catherine Meyer-Schwesinger; Hans-Willi Mittrücker; Gayle McEwen; Stefan H E Kaufmann
Journal:  J Clin Invest       Date:  2014-02-10       Impact factor: 14.808

5.  Cathepsin G and neutrophil elastase contribute to lung-protective immunity against mycobacterial infections in mice.

Authors:  Kathrin Steinwede; Regina Maus; Jennifer Bohling; Sabrina Voedisch; Armin Braun; Matthias Ochs; Andreas Schmiedl; Florian Länger; Francis Gauthier; Jürgen Roes; Tobias Welte; Franz C Bange; Michael Niederweis; Frank Bühling; Ulrich A Maus
Journal:  J Immunol       Date:  2012-03-28       Impact factor: 5.422

Review 6.  Neutrophils in tuberculosis: friend or foe?

Authors:  David M Lowe; Paul S Redford; Robert J Wilkinson; Anne O'Garra; Adrian R Martineau
Journal:  Trends Immunol       Date:  2011-11-15       Impact factor: 16.687

7.  An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis.

Authors:  Matthew P R Berry; Christine M Graham; Finlay W McNab; Zhaohui Xu; Susannah A A Bloch; Tolu Oni; Katalin A Wilkinson; Romain Banchereau; Jason Skinner; Robert J Wilkinson; Charles Quinn; Derek Blankenship; Ranju Dhawan; John J Cush; Asuncion Mejias; Octavio Ramilo; Onn M Kon; Virginia Pascual; Jacques Banchereau; Damien Chaussabel; Anne O'Garra
Journal:  Nature       Date:  2010-08-19       Impact factor: 49.962

Review 8.  Neutrophils in Tuberculosis: Heterogeneity Shapes the Way?

Authors:  Irina V Lyadova
Journal:  Mediators Inflamm       Date:  2017-05-24       Impact factor: 4.711

Review 9.  Neutrophil Extracellular Traps in Pulmonary Diseases: Too Much of a Good Thing?

Authors:  Bárbara Nery Porto; Renato Tetelbom Stein
Journal:  Front Immunol       Date:  2016-08-15       Impact factor: 7.561

Review 10.  Biomarkers of the involvement of mast cells, basophils and eosinophils in asthma and allergic diseases.

Authors:  Dean D Metcalfe; Ruby Pawankar; Steven J Ackerman; Cem Akin; Frederic Clayton; Franco H Falcone; Gerald J Gleich; Anne-Marie Irani; Mats W Johansson; Amy D Klion; Kristin M Leiferman; Francesca Levi-Schaffer; Gunnar Nilsson; Yoshimichi Okayama; Calman Prussin; John T Schroeder; Lawrence B Schwartz; Hans-Uwe Simon; Andrew F Walls; Massimo Triggiani
Journal:  World Allergy Organ J       Date:  2016-02-11       Impact factor: 4.084

View more
  6 in total

Review 1.  Isoniazid and host immune system interactions: A proposal for a novel comprehensive mode of action.

Authors:  Saifur R Khan; Yousef Manialawy; Arno G Siraki
Journal:  Br J Pharmacol       Date:  2019-11-12       Impact factor: 8.739

2.  Screening of potential biomarkers for distinguishing between latent and active tuberculosis in children using bioinformatics analysis.

Authors:  Meng Shao; Fang Wu; Jie Zhang; Jiangtao Dong; Hui Zhang; Xiaoling Liu; Su Liang; Jiangdong Wu; Le Zhang; Chunjun Zhang; Wanjiang Zhang
Journal:  Medicine (Baltimore)       Date:  2021-02-05       Impact factor: 1.817

Review 3.  Mycobacterium tuberculosis and Pulmonary Rehabilitation: From Novel Pharmacotherapeutic Approaches to Management of Post-Tuberculosis Sequelae.

Authors:  Andreea-Daniela Meca; Liliana Mititelu-Tarțău; Maria Bogdan; Lorena Anda Dijmarescu; Ana-Maria Pelin; Liliana Georgeta Foia
Journal:  J Pers Med       Date:  2022-04-02

4.  Reduced neutrophil granular proteins and post-treatment modulation in tuberculous lymphadenitis.

Authors:  Gokul Raj Kathamuthu; Kadar Moideen; Rathinam Sridhar; Dhanaraj Baskaran; Subash Babu
Journal:  PLoS One       Date:  2021-06-21       Impact factor: 3.240

Review 5.  Neutrophils in Tuberculosis-Associated Inflammation and Lung Pathology.

Authors:  Caleb N Muefong; Jayne S Sutherland
Journal:  Front Immunol       Date:  2020-05-27       Impact factor: 7.561

Review 6.  Eosinophil Polymorphonuclear Leukocytes in TB: What We Know so Far.

Authors:  Senbagavalli Prakash Babu; Prakash B Narasimhan; Subash Babu
Journal:  Front Immunol       Date:  2019-11-14       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.